Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions

García, Rebeca Reyes; Gimeno, Esteban Jódar; Martin, Allison; Muñoz, Manuel Romero; Sanchis, Javier; Fernández, Inés Luque; Varsavsky, Mariela; Iglesias, Sonsoles Guadalix; Rodríguez, Isidoro Cano; Pomar, María Dolores Ballesteros; Casariego, Alfonso Vidal; Moreno, Pedro R.; Berdonces, María Cortés; García, Diego Fernández; Canelas, Amparo Calleja; Moya, Mercedes Palma; Díaz-Guerra, Guillermo Martínez; Moleón, José Juan Jiménez; Torres, Manuel Muñoz

doi:10.1016/j.endoen.2012.01.004

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2012

2016

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(1 citation statement)

References 293 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the high prevalence of low BMD in ED (particularly in AN), there is no consensus regarding pharmacological prevention of osteopenia or osteoporosis. Guidelines are currently limited to preventative nutritional interventions and pharmacological interventions within the advanced phases of ED when damage has already occurred . The true extent of reduced BMD and risk for osteoporosis and fracture among people with ED is not known.…”

Section: Introductionmentioning

confidence: 99%